from concept to indication: neoadjuvant immunotherapy for operable lung cancer
Published 2 years ago • 168 plays • Length 56:12Download video MP4
Download video MP3
Similar videos
-
0:45
dr. jonathan villena-vargas on neoadjuvant therapy: enhancing lung cancer surgery success
-
4:41
immunotherapy for operable nsclc
-
2:31
differences in treating lung cancer with adjuvant and neoadjuvant immunotherapy
-
1:25
neoadjuvant therapy is taking off in lung cancer
-
1:31:16
pathologic response after neoadjuvant immunotherapy: facilitating progress in early-stage cancers
-
2:07
checkmate 816: addressing unanswered questions on surgical outcomes following neoadjuvant chemo-io
-
1:48
adjuvant and neoadjuvant chemo-io for uk patients with nsclc
-
0:58
adherence & outcomes of neoadjuvant immunotherapy in resectable nsclc
-
1:47
the development of surgery for lung cancer with the evolution of neoadjuvant/adjuvant treatment
-
48:44
neoadjuvant, adjuvant, or both: individualized perioperative immunotherapy in resectable nsclc
-
1:08
dr. donington on the role of neoadjuvant immunotherapy in stage ii nsclc
-
1:24
dr. kelly on preliminary data with neoadjuvant immunotherapy in lung cancer
-
24:30
s1 episode 4: managing lung cancer with neoadjuvant and adjuvant therapy
-
3:53
developments in neoadjuvant immunotherapy options for early-stage lung cancer patients
-
2:27
study finds neoadjuvant nivolumab to show long-term benefit in patients with nsclc
-
0:51
dr. kellie smith discusses immunotherapy breakthroughs for lung cancer treatment #immunotherapy
-
1:06:23
immunotherapy in lung cancer: rationale, evidence, and implications for the multidisciplinary team
-
6:20
response and safety profile of neoadjuvant nivolumab for resectable lung cancer